Wednesday, August 24, 2005


Treatments have same target, different responses for lung cancer
I-Newswire.com (press release) - Aug 20, 2005 The gene mutation that identifies the lung cancer patients most likely to respond to the drug gefitinib (Iressa) is not associated with a response to the drug

0 Comments:

Post a Comment

<< Home